News
GRTXD
16.50
-6.25%
-1.10
Weekly Report: what happened at GRTX last week (0706-0710)?
Weekly Report · 1d ago
Galera Therapeutics Announces Major Reverse Stock Split
TipRanks · 07/07 13:30
Weekly Report: what happened at GRTX last week (0629-0703)?
Weekly Report · 07/06 09:34
Weekly Report: what happened at GRTX last week (0622-0626)?
Weekly Report · 06/29 09:32
Weekly Report: what happened at GRTX last week (0615-0619)?
Weekly Report · 06/22 09:36
Weekly Report: what happened at GRTX last week (0608-0612)?
Weekly Report · 06/15 09:36
Weekly Report: what happened at GRTX last week (0601-0605)?
Weekly Report · 06/08 09:34
Weekly Report: what happened at GRTX last week (0525-0529)?
Weekly Report · 06/01 09:36
Weekly Report: what happened at GRTX last week (0518-0522)?
Weekly Report · 05/25 09:38
Galera Therapeutics Eliminates Series B Preferred, Simplifies Equity
TipRanks · 05/19 21:02
Galera Therapeutics converts Series B preferred into 42,839,103 common shares
PUBT · 05/19 20:02
Weekly Report: what happened at GRTX last week (0511-0515)?
Weekly Report · 05/18 09:38
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
TipRanks · 05/15 11:02
Galera Therapeutics bylaws grant shareholders right to act by written consent
PUBT · 05/15 10:31
Galera Therapeutics Q1 EPS $(0.01), Same YoY
Benzinga · 05/14 13:50
Galera net loss widens to $1.61 million in Q1 2026
PUBT · 05/14 11:16
Galera Shareholders Approve Governance Changes and Share Increase
TipRanks · 05/11 21:15
Galera Therapeutics shareholders approve reverse stock split authorization range 1-for-75 to 1-for-200
PUBT · 05/11 20:04
Weekly Report: what happened at GRTX last week (0504-0508)?
Weekly Report · 05/11 09:36
Galera Therapeutics files Form 3 beneficial ownership statement for Emerald Bioventures LLC
PUBT · 05/04 21:58
More
Webull provides a variety of real-time GRTXD stock news. You can receive the latest news about Galera Therapeutics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GRTXD
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.